Key result
Human metapneumovirus infection relies on complex interactions with host factors and viral receptors, such as heparan sulfate proteoglycans and integrins, for viral entry and replication.
Why the study?
Human metapneumovirus causes significant acute respiratory infections with no available vaccines or effective treatments, and host-virus interactions during pathogenesis require comprehensive elucidation.
Understanding the interactions between human metapneumovirus and host receptors provides a foundation for developing targeted antiviral therapies.
May support entry-inhibitor development for HMPV; leaves open clinical efficacy pending targeted trials.
Human metapneumovirus (hMPV) is a significant global pathogen that causes acute respiratory tract infections, especially in infants, young children, the elderly, and immunocompromised individuals. Despite its increasing prevalence, there are currently no vaccines or effective treatments available for hMPV. The pathogenesis of hMPV infection is a complex process involving a multitude of host factors and viral receptors. These interactions determine the virus ability to enter host cells, replicate, and evade the immune response. This review is the first to provide a comprehensive overview of the current understanding of host-virus interactions in hMPV pathogenesis. By elucidating these mechanisms, we can identify potential targets for antiviral drugs and improve the management of hMPV infections.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2025) conducted a review in Human metapneumovirus (hMPV) infection. Human metapneumovirus infection relies on complex interactions with host factors and viral receptors, such as heparan sulfate proteoglycans and integrins, for viral entry and replication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: